CanadaBis Capital Inc. (CANB.V)
| Previous Close | 0.3050 |
| Open | 0.2950 |
| Bid | 0.2950 x N/A |
| Ask | 0.3000 x N/A |
| Day's Range | 0.2950 - 0.3050 |
| 52 Week Range | 0.0500 - 0.3500 |
| Volume | |
| Avg. Volume | 53,590 |
| Market Cap | 41.477M |
| Beta (5Y Monthly) | 0.18 |
| PE Ratio (TTM) | 15.00 |
| EPS (TTM) | 0.0200 |
| Earnings Date | Nov 29, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
CNW GroupCANADABIS CAPITAL, WITH SUB STIGMA GROW, CONFIRMS ANOTHER RECORD FISCAL YEAR OF RESULTS IN 2023, HIGHLIGHTED BY SIGNIFICANT GROWTH IN NET REVENUE, GROSS PROFIT AND EARNINGS
CanadaBis Capital Inc. (the "Company" or "CanadaBis") (TSXV: CANB), a premium vertically integrated Canadian cannabis company, is pleased to announce another consecutive year of record results for the fiscal year ended July 31, 2023, and the eighth straight quarter generating positive net income. The Company's Financial Statements and Notes, as well as Management's Discussion and Analysis ("MD&A") are available on CanadaBis' website and filed on SEDAR at www.sedar.com.
CNW GroupCANADABIS CAPITAL, WITH SUB STIGMA GROW, ANNOUNCES INDUSTRY-LEADING ACHIEVEMENT AFTER WINNING PRODUCT OF THE YEAR AWARD AND PROVIDES CORPORATE UPDATE
CanadaBis Capital Inc. (the "Company" or "CanadaBis") (TSXV: CANB), a premium vertically integrated Canadian cannabis company, is proud to announce a landmark achievement with subsidiary Stigma Grow being the recipient of Grow Up Industry's coveted 2023 Product of the Year award for Dab Bods' Phoenix Tears ("Phoenix Tears"). We extend heartfelt congratulations to our dedicated employees at Stigma Grow, whose continued hard work and ongoing commitment to excellence have culminated in this award.
CNW GroupCANADABIS CAPITAL ANNOUNCES RESULTS OF SHAREHOLDERS MEETING AND THE APPOINTMENT OF GARFIELD RICHARDS AS CFO
CanadaBis Capital Inc. (the "Company" or "CanadaBis") (TSXV: CANB) a premium vertically integrated Canadian cannabis company, is pleased to report that at our Annual & Special Meeting (the "Meeting") held on August 30, 2023, all resolutions proposed to shareholders were duly passed.
